| Model of fibrolamellar hepatocellular carcinomas reveals striking enrichment in cancer stem cells T Oikawa, E Wauthier, TA Dinh, SR Selitsky, A Reyna-Neyra, G Carpino, ... Nature communications 6 (1), 8070, 2015 | 90 | 2015 |
| Comprehensive analysis of The Cancer Genome Atlas reveals a unique gene and non-coding RNA signature of fibrolamellar carcinoma TA Dinh, ECM Vitucci, E Wauthier, RP Graham, WA Pitman, T Oikawa, ... Scientific reports 7 (1), 44653, 2017 | 84 | 2017 |
| Transcriptomic analysis of chronic hepatitis B and C and liver cancer reveals microRNA-mediated control of cholesterol synthesis programs SR Selitsky, TA Dinh, CL Toth, CL Kurtz, M Honda, BR Struck, S Kaneko, ... MBio 6 (6), 10.1128/mbio. 01500-15, 2015 | 48 | 2015 |
| Genomic instability promoted by overexpression of mismatch repair factors in yeast: a model for understanding cancer progression U Chakraborty, TA Dinh, E Alani Genetics 209 (2), 439-456, 2018 | 37 | 2018 |
| Hepatocyte ABCA1 deletion impairs liver insulin signaling and lipogenesis CCC Key, M Liu, CL Kurtz, S Chung, E Boudyguina, TA Dinh, A Bashore, ... Cell reports 19 (10), 2116-2129, 2017 | 35 | 2017 |
| MicroRNA-375 suppresses the growth and invasion of fibrolamellar carcinoma TA Dinh, ML Jewell, M Kanke, A Francisco, R Sritharan, RE Turnham, ... Cellular and molecular gastroenterology and hepatology 7 (4), 803-817, 2019 | 34 | 2019 |
| Hotspots of aberrant enhancer activity in fibrolamellar carcinoma reveal candidate oncogenic pathways and therapeutic vulnerabilities TA Dinh, R Sritharan, FD Smith, AB Francisco, RK Ma, RP Bunaciu, ... Cell reports 31 (2), 2020 | 24 | 2020 |
| A framework for fibrolamellar carcinoma research and clinical trials TA Dinh, AF Utria, KC Barry, R Ma, GK Abou-Alfa, JD Gordan, EM Jaffee, ... Nature reviews Gastroenterology & hepatology 19 (5), 328-342, 2022 | 21 | 2022 |
| Inhibition of the chimeric DnaJ‐PKAc enzyme by endogenous inhibitor proteins AM Averill, HT Rehman, JW Charles, TA Dinh, K Danyal, ... Journal of Cellular Biochemistry 120 (8), 13783-13791, 2019 | 10 | 2019 |
| Multiomic analysis of microRNA-mediated regulation reveals a proliferative axis involving miR-10b in fibrolamellar carcinoma AB Francisco, M Kanke, AP Massa, TA Dinh, R Sritharan, K Vakili, ... JCI insight 7 (11), 2022 | 9 | 2022 |
| HUMAN FIBROLAMELLAR HEPATOCELLULAR CARCINOMAS (hFL-HCCS) E Wauthier, T Oikawa, TA Dinh, P Sethupathy, LM Reid US Patent App. 15/061,626, 2016 | 7 | 2016 |
| Compositions and methods for bioengineered tissues AD Hanson, M Yamauchi, EL Wauthier, TA Dinh, P Sethupathy, LM Reid US Patent App. 15/586,061, 2017 | 2 | 2017 |
| Human fibrolamellar hepatocellular carcinomas (hFL-HCCs) E Wauthier, T Oikawa, TA Dinh, P Sethupathy, LM Reid US Patent 11,932,877, 2024 | | 2024 |
| Compositions and methods for bioengineered tissues AD Hanson, M Yamauchi, EL Wauthier, TA Dinh, P Sethupathy, LM Reid US Patent App. 16/681,660, 2020 | | 2020 |
| Hotspots of aberrant enhancer activity in fibrolamellar carcinoma reveal molecular mechanisms of oncogenesis and intrinsic drug resistance TA Dinh, R Sritharan, FD Smith, AB Francisco, RK Ma, RP Bunaciu, ... bioRxiv, 2020.01. 18.911297, 2020 | | 2020 |
| Compositions and methods for bioengineered tissues AD Hanson, M Yamauchi, EL Wauthier, TAH Dinh, P Sethupathy, LM Reid | | 2019 |
| Genome-scale Approaches to Identifying Novel Regulators of Fibrolamellar Carcinoma T Dinh | | 2019 |
| Yap1 As a Therapeutic Target in Fibrolamellar Carcinoma M Jewell, RT Premont, J Gibson, W Glover, TA Dinh, EL Wauthier, ... HEPATOLOGY 68, 1243A-1243A, 2018 | | 2018 |
| Genetics: Early Online, published on April 13, 2018 as 10.1534/genetics. 118.300923 U Chakraborty, TA Dinh, E Alani | | 2018 |
| Compositions and methods for bioengineered tissues AD HANSON, M Yamauchi, EL WAUTHIER, TAH Dinh, P Sethupathy, ... | | 2017 |
Adam B FranciscoCornell UniversityVerified email at cornell.edu
